Difficulty: Medium
Average Score: 92%
Practice
The immunosuppressive regimen in pediatric kidney transplant recipients typically includes
Correct answer
B
Rationale
In pediatric kidney transplant recipients, the immunosuppressive regimen typically includes calcineurin inhibitors and steroids (Option B) for several reasons. Calcineurin inhibitors like tacrolimus or cyclosporine are essential in preventing organ rejection by inhibiting T-cell activation. Steroids, such as prednisone, are also crucial as they have broad anti-inflammatory and immunosuppressive effects, further reducing the risk of rejection.
Option A, using steroids alone, is not the preferred choice in pediatric kidney transplant recipients because it may not provide adequate immunosuppression to prevent rejection, leading to graft failure. Mycophenolate mofetil (Option C) is commonly used in combination with calcineurin inhibitors and steroids, rather than as a standalone therapy, due to its synergistic immunosuppressive effects. Sirolimus (Option D) is another immunosuppressant, but it is not typically used as the primary agent in pediatric kidney transplant recipients due to concerns about its nephrotoxicity and limited efficacy compared to calcineurin inhibitors.
Educationally, understanding the rationale behind the immunosuppressive regimen in pediatric kidney transplant recipients is crucial for pediatric genitourinary nurses. It ensures optimal care for these vulnerable patients, minimizes the risk of rejection, and promotes successful long-term outcomes post-transplantation. By grasping the principles of immunosuppression in this context, nurses can effectively monitor for complications, educate patients and families, and collaborate with the healthcare team to provide comprehensive care.
Option A, using steroids alone, is not the preferred choice in pediatric kidney transplant recipients because it may not provide adequate immunosuppression to prevent rejection, leading to graft failure. Mycophenolate mofetil (Option C) is commonly used in combination with calcineurin inhibitors and steroids, rather than as a standalone therapy, due to its synergistic immunosuppressive effects. Sirolimus (Option D) is another immunosuppressant, but it is not typically used as the primary agent in pediatric kidney transplant recipients due to concerns about its nephrotoxicity and limited efficacy compared to calcineurin inhibitors.
Educationally, understanding the rationale behind the immunosuppressive regimen in pediatric kidney transplant recipients is crucial for pediatric genitourinary nurses. It ensures optimal care for these vulnerable patients, minimizes the risk of rejection, and promotes successful long-term outcomes post-transplantation. By grasping the principles of immunosuppression in this context, nurses can effectively monitor for complications, educate patients and families, and collaborate with the healthcare team to provide comprehensive care.